ReGelTec: Implanting a Solution for Degenerative Disc Disease

article image

By restoring vertebral disc height with an injectable, durable hydrogel, ReGelTec aims to give interventional spine and pain clinicians an effective option for one of the most common causes of low back pain.

As many as 80% of people in the US experience low back pain at some point in life, making it one of the most common symptoms prompting a doctor visit. For those with degenerative disc disease (DDD), which typically appears around age 40 and is influenced by genetics and lifestyle factors such as repetitive motion, that pain is chronic and a detriment to quality of life. 

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: